F 0624
Prepare residents for a safe transfer or discharge from the nursing home.
Level of Harm - Minimal harm
or potential for actual harm
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on
interview and record review the facility failed to ensure for safe discharge plan to address resident's health
and safety needs for one of two sampled residents (Resident 1) when Resident 1's blood glucose
monitoring (using a device to automatically estimate blood glucose levels) and insulin (insulin: a hormone
controls blood sugars) administration was not address upon discharge to the board and care home (B&C
home: a residential house that provides care for a small group of seniors). This failure could potentially
affect the Resident 1's health and wellness upon discharge from the facility.
Residents Affected - Few
Findings:
Review of Resident 1's face sheet (FS: a document that gives a resident's information at a quick glance)
undated indicated, Resident 1 was admitted to facility on 8/28/2023. Resident 1's FS also indicated, he was
admitted with diagnoses including type 1 diabetes mellitus (a disease in which the body does not make
enough insulin to control blood sugar levels), hyperglycemia (increased blood sugar levels), long term use
of insulin, carpel tunnel syndrome (a numbness and tingling sensation in the hand and arm caused by a
pinched nerve in the wrist), chronic viral hepatitis C (an infection caused by a virus that attacks the liver),
and need for assistance with personal care. Resident 1 was discharged to B&C home on 9/12/023.
Review of Resident 1's minimum data set (MDS: Clinical functional assessment tool) assessment dated
[DATE] indicated Resident 1's brief interview for mental status (BIMS) score of 14 of 15 (13-15: cognitively
intact).
Review of Resident 1's physician orders dated 8/28/2023 indicated, Resident 1 had an order for Humalog
(fast acting insulin used to treat to control high blood sugar levels in the body) Solution 100 Unit/ML (unit
per milliliter: a unit of fluid volume equal to one-thousandth of a liter) Inject as per sliding scale (SS: varies
the dose of insulin based on the blood glucose level): If 0-60 =0 units, Follow hypoglycemia (low blood
sugar levels) Protocol; 70-150 =0 units; 151 -200 =2 units; 201-250=4 units; 251-300 =6 units; 301 -350 =8
units; 351 -400 =10 units; 401 + call Prescriber, subcutaneously (a short needle is used to inject a drug just
under the skin) with meals and as needed for diabetes.
Review of Resident 1's physician orders dated 8/28/2023 indicated, Resident had an order for Humalog
100 Units/ML Inject as per SS: If 0-69 =0 units, Follow hypoglycemia Protocol; 70-150= 0 units; 151-200=1
units; 201-250= 2 units; 251-300 = 3 units; 301-350 = 4 units; 351-400 = 5 units; 401+call Prescriber,
subcutaneously at bedtime for diabetes.
Review of Resident 1's physician orders dated 9/05/2023 indicated, Insulin Glargine (long-acting
(continued on next page)
Any deficiency statement ending with an asterisk (*) denotes a deficiency which the institution may be excused from correcting providing it is determined that other
safeguards provide sufficient protection to the patients. (See instructions.) Except for nursing homes, the findings stated above are disclosable 90 days following the
date of survey whether or not a plan of correction is provided. For nursing homes, the above findings and plans of correction are disclosable 14 days following the date
these documents are made available to the facility. If deficiencies are cited, an approved plan of correction is requisite to continued program participation.
LABORATORY DIRECTOR'S OR PROVIDER/SUPPLIER
REPRESENTATIVE'S SIGNATURE
TITLE
(X6) DATE
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Facility ID:
If continuation sheet
Page 1 of 3
Event ID:
055866
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
055866
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
10/31/2023
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Plum Tree Care Center
2580 Samaritan Drive
San Jose, CA 95124
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0624
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Few
insulin that works slowly over about 24 hours to control blood sugar levels) Solution 100 Units/ML Inject 30
units subcutaneously every 12 hours for diabetes.
Review of Resident 1's physician orders upon discharge to B&C home on 9/12/2023 indicated, insulin
glargine 100 unit/ml solution inject 30 units subcutaneously every 12 hours, Humalog solution 100 units/ml
inject subcutaneously as per sliding scale with each meal, at bedtime, and as needed for diabetes.
Review of Resident 1's physician orders dated 9/11/2023 indicated, May DC home 9/12/2023 w/PT
(physical therapy: a care that aims to ease pain, and help function, move and strengthen muscles) /OT
(occupational therapy: helps to learn and regain skills of daily living)/ RN (registered nurse: licensed
medical professional who provides hands- on care to residents)/HH (home health: a wide range of health
care services that can be given at home for an illness or injury).
Resident 1's IDT (interdisciplinary team: a group of dedicated healthcare professionals who work together
to provide the care resident needs and when needed) planned Discharge summary dated [DATE] indicated,
Resident 1 was discharge with medication list. Further review of this discharge summary indicated, no
documented evidence of IDT discussed and implemented the plan to meet Resident 1's blood glucose
monitoring, and insulin administration care needs at B&C home after discharged from facility on 9/12/2023.
Review of Resident 1's nursing Discharge summary dated [DATE] at 17:26 indicated, Pt discharged to B&C
home @ 1600. Pt discharged on w/c (wheelchair: a chair on wheels that people who are unable to walk use
for moving around), picked up by the driver of the receiving facility.
Review of Resident 1's clinical record indicated, there was no documented evidence of facility planned,
implemented, and confirmed to meet Resident 1's blood glucose monitoring, and insulin administration care
at the B&C home after his discharge from facility. Further review of Resident 1's clinical record indicated,
there was no documented evidence of B&C home staff evaluated Resident 1's blood glucose monitoring,
and insulin administration care needs to meet at the B&C home before accepted Resident 1 from facility.
During an interview with primary care physician (PCP) for Resident 1 on 10/12/2023 at 12:30 p.m., PCP
stated she (PCP) was not involved with discharge plan for Resident 1. PCP confirmed Resident 1 needed
to continue monitoring for blood glucose and insulin administration for diabetes at B&C home. PCP also
stated facility did not verify whether B&C home was capable to continue Resident 1's insulin administration,
and blood glucose monitoring care at B&C home before discharged Resident 1. PCP further stated facility
unsafely discharged Resident 1 to B&C home without evaluated and confirmed the B&C home's capabilities
to meet Resident 1's need for on-going diabetes management.
During a concurrent interview and record review with licensed vocational nurse/unit manager A (LVN/UM A)
on 10/12/2023 at 2:05 p.m., LVN/UM A confirmed she attended IDT discharge meeting for Resident 1 on
9/11/2023. LVN/UM A also confirmed Resident 1 was discharged to B&C home with physician orders
including blood glucose monitoring and insulin administration on 9/12/2023.
LVN/UM A stated IDT did not discuss the plan for Resident 1 ' s blood glucose monitoring, and insulin
administration care needs at B&C home upon discharge from facility to B&C home. LVN/UM A further
stated facility should have discussed and planned safe discharge to meet Resident 1's blood glucose
management at the B&C home before discharged from facility.
(continued on next page)
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
055866
If continuation sheet
Page 2 of 3
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
055866
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
10/31/2023
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Plum Tree Care Center
2580 Samaritan Drive
San Jose, CA 95124
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0624
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Few
During an interview with social service director (SSD) on 10/12/2023 at 2:15 p.m., SSD confirmed Resident
1 had physician orders for blood glucose monitoring and insulin administration at B&C home. SSD also
confirmed IDT did not discuss Resident 1's blood glucose monitoring, and insulin administration care needs
at the B&C home after discharge from facility. SSD stated staff from B&C home did not evaluate Resident
1's care needs to meet for blood glucose monitoring and insulin administration at B&C home upon the
discharge from facility. SSD also stated facility failed to verify and confirm whether B&C home had the
capacity to monitor blood glucose, and administer insulin as ordered by physician before discharged to
B&C home on 9/12/2023. SSD further stated facility should have discharged Resident 1 with a safe
discharge plan to meet blood glucose monitoring and insulin administration arrangements at B&C home as
required for Resident 1 before discharged him to B&C home from facility.
During a concurrent interview and record review with director of nursing (DON) on 10/12/2023 at 3:45 p.m.,
DON confirmed IDT did not discuss the plan to meet Resident 1's blood glucose monitoring, and insulin
administration orders at the B&C home after discharged from facility. DON stated IDT should have
discussed, planned, and arranged to meet diabetic care needs at B&C home for a safe discharge plan for
Resident 1. DON also stated SSD should have verified and confirmed with B&C home to meet Resident 1's
on-going diabetic management care before Resident 1 discharge to the B&C home. DON further stated
Resident 1 had unsafe discharge to B&C home.
Review of facility's policy and procedure (P&P) titled, Discharging the Resident, dated 7/1/2020, the P&P
indicated, If the resident is being discharged home, ensure that resident and/or responsible party (RP: who
is given authority to act on behalf of the resident for daily decision making) receive teaching and discharge
instructions.
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
055866
If continuation sheet
Page 3 of 3